Stockreport

TG Therapeutics: Flawless Execution And $500 Million Non-Dilutive Capital Bolster Outlook [Seeking Alpha]

TG Therapeutics, Inc.  (TGTX) 
Last tg therapeutics, inc. earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
PDF Briumvi IV continues to gain market share in MS, while the SC version's trial is fully enrolled and could double the addressable market. Management guides conservativ [Read more]